XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Common Stock and Stock-Based Compensation
3 Months Ended
Mar. 26, 2022
Share-based Payment Arrangement [Abstract]  
Common Stock and Stock-Based Compensation . Common Stock and Stock-Based Compensation

 

Option Activity

 

Information related to stock options under the Restated Employee Equity Incentive Plan and the Stock Option Plan for Non-Employee Directors is summarized as follows:

 

 

 

Shares

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term in Years

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 25, 2021

 

 

221,354

 

 

$

310.38

 

 

 

 

 

 

 

Granted

 

 

17,114

 

 

 

383.46

 

 

 

 

 

 

 

Exercised

 

 

(12,014

)

 

 

198.13

 

 

 

 

 

 

 

Outstanding at March 26, 2022

 

 

226,454

 

 

$

321.86

 

 

 

5.71

 

 

$

27,690

 

Exercisable at March 26, 2022

 

 

111,689

 

 

$

240.29

 

 

 

4.84

 

 

$

17,493

 

Vested and expected to vest at March 26, 2022

 

 

204,649

 

 

$

313.40

 

 

 

5.62

 

 

$

25,752

 

 

Of the total options outstanding at March 26, 2022, 8,057 shares were performance-based options for which the performance criteria had yet to be achieved.

 

On March 1, 2022, the Company granted options to purchase an aggregate of 17,114 shares of the Company’s Class A Common Stock to senior management with a weighted average fair value of $178.10 per share and a weighted average exercise price of $383.46 per share, of which all shares relate to performance-based stock options.

 

Weighted average assumptions used to estimate fair values of stock options on the date of grants are as follows:

 

 

 

2022

 

Expected Volatility

 

 

37.9

%

Risk-free interest rate

 

 

1.9

%

Expected Dividends

 

 

0.0

%

Exercise factor

 

2.8

 

Discount for post-vesting restrictions

 

 

1.0

%

 

Non-Vested Shares Activity

 

The following table summarizes vesting activities of shares issued under the investment share program and restricted stock awards:

 

 

 

Number of Shares

 

 

Weighted Average Fair Value

 

Non-vested at December 25, 2021

 

 

88,848

 

 

$

401.70

 

Granted

 

 

41,946

 

 

 

344.41

 

Vested

 

 

(24,308

)

 

 

310.66

 

Forfeited

 

 

(1,829

)

 

 

496.86

 

Non-vested at March 26, 2022

 

 

104,657

 

 

$

403.50

 

 

 

Of the total shares outstanding at March 26, 2022, 1,348 shares were performance-based shares for which the performance criteria had yet to be achieved.

 

On March 1, 2022, the Company granted a combined 31,101 shares of restricted stock units to certain officers, senior managers and key employees, of which all shares vest ratably over service periods of four years. Additionally on March 1, 2022, employees elected to purchase a combined 10,845 shares under the Company’s investment share program. The weighted average fair value of the restricted stock units and investment shares, which are sold to employees at discount under its investment share program, was $383.46 and $232.41 per share, respectively.

 

Stock-Based Compensation

 

The following table provides information regarding stock-based compensation expense included in operating expenses in the accompanying condensed consolidated statements of comprehensive operations:

 

 

 

Thirteen weeks ended

 

 

 

March 26,
2022

 

 

March 27
2021

 

 

 

(in thousands)

 

Amounts included in advertising, promotional and selling expenses

 

$

1,227

 

 

$

1,672

 

Amounts included in general and administrative expenses

 

 

1,695

 

 

 

3,285

 

Total stock-based compensation expense

 

$

2,922

 

 

$

4,957